Repeated Suppression Of Creutzfeldt-Jakob Disease With Vidarabine
Jr. , et al, Lancet 2:564-56582., Furlow,T.W., 1982
Long-Term Follow-up of Patients with Subacute Sclerosing Panencephalitis Treated with Inosiplex
Ann Neurol 11:359-364, Dyken,P.R.,et al, 1982
Acyclovir
BMJ 285:1223-1224, Timbury,M.C., 1982
Progressive Multifocal Leukoencephalopathy:Failure of Cytarabine Therapy
Neurol 32:200-203, Smith,C.R.,et al, 1982
Duration of Vidarabine Therapy in Biopsy-Negative Herpes Simplex Encephalitis
JAMA 247:332-334, Landry,M.L.,et al, 1982
Intrathecal Interferon in Multiple Sclerosis
Arch Neurol 39:609-615, Jacobs,L.,et al, 1982
Intrathecal Use Of Interferon In Encephalitis
NEJM 305:1283-1284, Prange,H.,et al, 1981
Herpes-zoster Myelitis Treated Successfully with Vidarabine
BMJ 283:698-699, Corston,R.N.,et al, 1981
Fatal Vidarabine Toxicity in a Patient With Normal Renal Function
JAMA 246:1703-1705, VanEtta,L.,et al, 1981
Herpes Simplex Encephalitis
NEJM 304:313-318, Whitley,R.J.,et al, 1981
Progressive Multifocal Leukoencephalopathy
Arch Neurol 37:497-501, Boudewijn,A.C.,et al, 1980
The Clinical Management of Suspected Herpes Virus Encephalitis
Am J Med 69:895-902, Braun,P., 1980
Antiviral Agents, (First of Two Parts, )
NEJM 302:903-907, Hirsch,M.S.,et al, 1980
Antiviral Agents, (Second of Two Parts)
NEJM 302:949-953, Hirsch,M.S.,et al, 1980
Failure of Interferon to Modify Creutzfeldt-Jakob Disease
BMJ 280:902, Kovanen,J.,et al, 1980
Review of 38 Cases of S. S. P. E. :Effect of Amantadine on the Natural Course of the Disease
Jr. , et al, Ann Neurol 8:422-42580., Robertson,W.C., 1980
The Decision to Biopsy, Treat, or Wait in Suspected Herpes Encephalitis
Ann Int Med 92:641-649, Barza,M.,et al, 1980
Brain Biopsy in Herpes Simplex Encephalitis
NEJM 303:700-701, Caplan,L.R., 1980
Herpes Simplex Encephalitis:Need for Accurate Diagnosis
JAMA 244:371-372, Whitley,R.J.,et al, 1980
Follow-up Of Interferon Treatment Of Herpes Simplex
NEJM 303:699-700, Haverkos,H.W.,et al, 1980
Clinical Pathological Conference
Herpes Simplex Encephalitis, Case Record 44-1979, NEJM 301:987-994979., , 1979
Post-Infectious Encephalomyelitis After Successful Treatment of Herpes Simplex Encephalitis with Adenine Arabinoside
NEJM 300:1089-1093, Koenig,H.,et al, 1979
Prevention Of Reactivated Herpes Simplex Infection By Human Leukocyte Interferon After Operation On The Trigeminal Root
NEJM 301:225-230, Paxin,G.J.,et al, 1979
Adenine Arabinoside Therapy of Biopsy-proved Herpes Simplex Encephalitis
NEJM 297:289, Whitley,R.J.,et al, 1977
Early Diagnosis of Herpes Rncephalitis
H. , et al, NEJM 297:1288, 1977. (Letter), Adams,J., 1977
Herpes Simplex Encephalitis Treated with Vidarbine (Adenine Arabinoside)
Arch Neurol 34:608, Taber,L.H.,et al, 1977
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Neuropathy Due to Cytosine Arabinoside
BMJ 2:652-653, Russell,J.A.,et al, 1974
Idoxuridine in Herpes Simplex Virus (Type 1) Encephalitis
Ann Int Med 78:243-246, Nolan,D.C.,et al, 1973
Chemotherapy of Viral Infections
NEJM 289:725, Weinstein,J., 1973
IUDR:Given Intraventricularly in the Treatment of PML
Cancer Chemoter Repts 57:73, Tarsy,D.,et al, 1973
Cytosine Arabinoside Versus Virus or Man
NEJM 289:912, Karchmer,A.W., 1973
Case Records of MGH-NEJM 286:1047
1972 Progressive Multifocal Leukoencephalopathy., , 1972
Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026
Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026
Tenecteplase for Acute Non-Large Vessel Occlusion 4.5 to 24 Hours After IschemicStroke, The OPTION Randomized Clinical Trial
JAMA doi:10.1001/JAMA.2026.0210, Ma,G.,et al, 2026
A Randomized Trial of Tenecteplase in Acute Central Retinal Artery Occlusion
NEJM 394:442-450, Ryan,S.J.,et al, 2026
Mucormycosis
NEJM 394:684-698, Kontoyiannia,D.P. & Walsh, T.J., 2026
Secondary Prevention after Ischemic Stroke
NEJM 394:784-792, Frie,K.L.,et al, 2026
Zorevunersen in Children and Adolescents with Dravet Syndrome
NEJM 394:969-982, Laux,L.,et al, 2026
Niemann-Pick Type C Disease
www.UpToDate.com, Nov, Schiffmann, R., 2026
Bilateral Posterior Limb Internal Capsule T2 Hyperintensity and Severe Cerebellar Atrophy in 2 Lifelong Friends
Neurol 106:e218014, Inoue,H.,et al, 2026
Status Epilepticus After Carotid Endarterectomy:An Illustrative Case of Cerebral Hyperfusion Syndrome
Stroke 57:e188-191, Reuter,P.,et al, 2026
Endovascular Therapy for Medium-Vessel Occlusion Stroke - Narrowing the Target Population
NEJM 394:1955-1957,1894, Ospel,J.M. & Hill, M.D., 2026
A 35-Year-Old Patient with Rapidly Progressive Ascending Weakness Leading to Loss of Brainstem Reflexes
Neurol 106:e218059, Lyons,H.J.,et al, 2026
Safety and Outcomes of Dibigatran Reversal with Idarucizumab Before IV Thrombolysis in Patients with Acute Ischemic Stroke
Neurol 106:e218012, Saflund,M.,et al, 2026
A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026
Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025